Home Healthcare Medical Devices Lacrimal Devices Market

Lacrimal Devices Market Size, Share & Trends Analysis Report By Product (Intubation Sets, Stents and Tubes, Cannula and Spatula, Dilators), By Application (Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora, Others), By End-User (Hospital, Diagnostic Center, Ambulatory Care Center (ACC)) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Lacrimal Devices Market Size

The global lacrimal devices market size was valued at USD 160.77 million in 2025 and is projected to grow from USD 166.40 million in 2026 to USD 219.11 million by 2034, registering a CAGR of 3.5% during the forecast period from 2026 to 2034. North America dominated the lacrimal devices market with a market share of 38.5% in 2025.

The lacrimal gland secretes the aqueous portion of the tear film and maintains the ocular surface with a thin layer of the tear. The lacrimal apparatus consists of two components the lacrimal glands, which secrete the tears, and the lacrimal sac and ducts, which transmit the tears into the nasal cavity. The lacrimal devices aim to repair the lacrimal drainage system. Epiphora caused by obstructions in lacrimal drainage is a common lacrimal illness. Depending on the pathophysiology of the problem, DCR or simple probing could be used to treat the issue. The lacrimal drainage system is repaired with lacrimal devices such as stents and intubation sets. These devices target the lacrimal ducts and nasal or lacrimal punctum of the eye particularly. During the projected time, the market will advance due to the launch of innovative, high-success-rate treatments. The adoption of precise and modern lacrimal devices is a fundamental market growth factor.

Lacrimal Devices Market Size

Download a Free Sample To learn more about this report.

Products Insights

The market is segmented into intubation sets, stents and tubes, cannula and spatula, and dilators. The stents and tubes segment holds the largest share in the lacrimal devices market on account of the rising prevalence of eye diseases and the surging need for eye-related surgical procedures. Stents are inert, pliable, self-retaining, available, and simple to use, and have a smooth external surface that eliminates any chances of mechanical damage to surrounding soft tissues.

Lacrimal Devices Market Size By Segments

Request Customizationto receive a tailored report.

Applications Insights

The market is segmented into glaucoma, dry eye, lacrimal gland inflammation, epiphora, and others. The glaucoma segment is projected to experience the most growth. Microsurgery and laser surgery are advised for the treatment of glaucoma. With microsurgery, the physician may implant a tube to aid in fluid drainage.

End-User Insights

The market is segmented into hospitals, diagnostic centers, and ambulatory care centers. The hospital segment accounted for the largest share of the lacrimal devices market. The increasing prevalence of eye diseases, the growing number of patient visits to hospitals, the increasing number of patients undergoing surgical procedures, and the availability of reimbursement for these procedures drive segment growth.

Lacrimal Devices Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North Americadominates the lacrimal devices market as the region is backed by the presence of a well-established healthcare system, the high adoption rate of lacrimal devices, along with the surging prevalence of eye diseases. Increasing consumer awareness about eye care and government initiatives drive regional market growth. Additionally, the rising geriatric population and the presence of key players are further anticipated to propel the market growth. In addition, research and development, the presence of rivals, product launches, patents, and approvals in the field of medical devices and pharmaceuticals in North America contribute to the expansion of the market. The U.S. will hold the largest share over the research period due to its robust medical industry and high healthcare spending. Advanced and modern medical and ophthalmic facilities, as well as a considerable surge in lacrimal diseases, are boosting the demand for lacrimal devices.

Europe Market

The Europe Lacrimal Devices Market is anticipated to expand substantially over the forecast period. The expansion of the market is attributable to the rising demand for advanced healthcare services in the region. The rise in the frequency of various eye illnesses throughout the region is one of the factors driving market expansion. Increased emphasis on R&D by manufacturers to develop innovative therapies, as well as shifting regional and demographic trends, drive market expansion. Increased government and non-government activities for various eye ailments, such as glaucoma, as well as a rise in the incidence of obesity and diabetes, which has led to an increase in ophthalmic problems, also influence the market.

North America Lacrimal Devices Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Market

Asia-Pacific is also anticipated to demonstrate a substantial growth rate in the lacrimal device market over the coming years. Numerous types of eye conditions, such as glaucoma and dry eye, are prevalent in densely populated nations such as India and China, where a large proportion of the population is affected. In addition, the expanding number of domestic enterprises in the Asia-Pacific will stimulate market revenue. China dominates the Asia-Pacific market as a result of rising healthcare costs per capita and a number of government initiatives for integrated treatment systems in the region. Moreover, India is expanding substantially due to a sustained emphasis on enhancing surgical equipment norms and regulations and increasing public awareness regarding procedures in cases of lacrimal duct obstruction and other eye-related disorders.

Latin America Market

The increasing senior population, which is more prone to chronic eye-related problems, is one of the key drivers driving the market in Latin America. In addition, the increasing use of contact lenses is also driving market expansion. In addition, numerous product advances, including secretagogues and neurostimulation devices to temporarily stimulate the lacrimal gland and improve natural tear production, are operating as key growth-inducing factors. In addition to this, the increasing use of consumer electronic devices, such as computers, cell phones, televisions, etc., is expanding the regional market. In addition, the development of sophisticated diagnostic technologies and the expansion of healthcare infrastructures are anticipated to boost the market in LAMEA throughout the forecast period.

List of Key and Emerging Players in Lacrimal Devices Market

FCI Ophthalmic
Kaneka Corporation
Lacrimedics, Inc.
Cook Group
BVI
Rumex International
Bess Medical Technology GmbH
Alcon
Bausch and Lomb Incorporated
BraunMelsungen AG.

Key Industry Developments

April 2025
Nordic Pharma received CE Mark approval for LACRIFILL®, expanding the availability of its canalicular gel technology for the treatment of dry eye disease across European markets.
February 2025
Alcon commercially launched the Voyager™ Direct Selective Laser Trabeculoplasty (DSLT) system in the U.S., expanding its ophthalmic treatment portfolio with an automated device for glaucoma and ocular hypertension.
January 2025
Alcon launched the UNITY® Vitreoretinal Cataract System (VCS) and UNITY® Cataract System (CS), expanding its ophthalmic surgical platform with next-generation technologies supporting advanced eye procedures.

Report Scope

Segmentation

By Product 4
  • Intubation Sets
  • Stents and Tubes
  • Cannula and Spatula
  • Dilators
By Application 5
  • Glaucoma
  • Dry Eye
  • Lacrimal Gland Inflammation
  • Epiphora
  • Others
By End-User 3
  • Hospital
  • Diagnostic Center
  • Ambulatory Care Center (ACC)

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage FCI Ophthalmic · Kaneka Corporation · Lacrimedics, Inc. · Cook Group · BVI
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The lacrimal devices market size is valued at USD 166.40 Million in 2026 and is projected to reach USD 219.11 Million by 2034, at a CAGR of 3.5% during the forecast period 2026-2034.
North America dominated the market with a share of 38.5% in 2025.
The leading players in this market are FCI Ophthalmic, Kaneka Corporation, Lacrimedics, Inc., Cook Group.
The lacrimal devices market is projected to grow at a CAGR of 3.5% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now